Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
22.12
-0.03 (-0.14%)
At close: Oct 8, 2025, 4:00 PM EDT
22.13
+0.01 (0.05%)
After-hours: Oct 8, 2025, 4:00 PM EDT

Beta Bionics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Net Income
-73.37-54.76-44.1-64.75
Depreciation & Amortization
2.42.282.092.09
Other Amortization
---0.01
Loss (Gain) From Sale of Assets
0.020.020.010.04
Loss (Gain) From Sale of Investments
-2.97-2.91-0.75-
Stock-Based Compensation
11.136.385.666.1
Provision & Write-off of Bad Debts
0.030.070.05-
Other Operating Activities
17.8612.789.9-0.91
Change in Accounts Receivable
-2.46-7.62-4.49-
Change in Inventory
-9.49-11.44-1.19-
Change in Accounts Payable
0.521.520.72-0.08
Change in Unearned Revenue
2.332.460.34-0.18
Change in Other Net Operating Assets
-3.452.94-0.68-2.53
Operating Cash Flow
-57.46-48.27-32.45-60.21
Capital Expenditures
-4.59-3.4-0.4-0.77
Sale of Property, Plant & Equipment
-0.0500
Investment in Securities
-182.78-0.13-69.3-
Investing Cash Flow
-187.37-3.48-69.69-0.77
Issuance of Common Stock
211.250.10.030.39
Other Financing Activities
-4.03-4.15-11.41
Financing Cash Flow
266.8855.62101.0356.78
Net Cash Flow
22.053.87-1.11-4.2
Free Cash Flow
-62.06-51.67-32.85-60.98
Free Cash Flow Margin
-79.53%-79.34%-273.84%-34067.04%
Free Cash Flow Per Share
-2.84-8.12-6.19-12.20
Levered Free Cash Flow
--35.24-19.66-
Unlevered Free Cash Flow
--35.24-19.66-
Change in Working Capital
-12.55-12.15-5.31-2.79
Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q